Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jacinta Leyden, M.D.

Concepts (13)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Jacinta Leyden's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Jacinta Leyden has written about over time.
Adult, 1 publications between 2024 and 2024, average publication date February 2024. Aged, 1 publications between 2024 and 2024, average publication date February 2024. Comorbidity, 1 publications between 2024 and 2024, average publication date February 2024. Diabetic Ketoacidosis, 1 publications between 2024 and 2024, average publication date February 2024. Female, 1 publications between 2024 and 2024, average publication date February 2024. Hospitalization, 1 publications between 2024 and 2024, average publication date February 2024. Humans, 1 publications between 2024 and 2024, average publication date February 2024. Hyperglycemic Hyperosmolar Nonketotic Coma, 1 publications between 2024 and 2024, average publication date February 2024. Male, 1 publications between 2024 and 2024, average publication date February 2024. Massachusetts, 1 publications between 2024 and 2024, average publication date February 2024. Mental Disorders, 1 publications between 2024 and 2024, average publication date February 2024. Middle Aged, 1 publications between 2024 and 2024, average publication date February 2024. Retrospective Studies, 1 publications between 2024 and 2024, average publication date February 2024.

To see the data from this visualization as text, click here.
Leyden's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (13)
Explore
_
Co-Authors (2)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.